GPLB
What one share of Green Planet Bioengineering Co. holds
Biological Products, (No Diagnostic Substances)
Green Planet Bioengineering Co., Ltd. (“Green Planet” or “Company”) operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation.
Green Planet Bioengineering Co.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2019-09-30.
| Profit | −$0.00 |
|---|---|
| Cash and investments | $0.00 |
| Book value | −$0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | — | −$0.00 | — | $0.00 | — | −$0.01 |
| 2017 | — | −$0.00 | — | $0.00 | — | −$0.01 |
| 2018 | — | −$0.00 | — | −$0.00 | — | −$0.01 |
| 2019 | — | −$0.00 | — | −$0.00 | — | −$0.01 |
| 2020 | — | −$0.00 | — | −$0.00 | — | −$0.02 |
| 2021 | — | −$0.00 | — | −$0.00 | — | −$0.02 |
| 2023 | — | −$0.00 | — | −$0.00 | — | −$0.02 |
| 2024 | — | −$0.00 | — | −$0.00 | — | −$0.02 |
| 2025 | — | −$0.00 | — | −$0.00 | — | −$0.03 |